배호성 (University of California Irvine) | 한빛사논문 > 한빛사

한빛사논문

조회178

배호성Hosung Bae

University of California Irvine

CV File 322 kb

Circ. Res., May 23 2025, 136 (11) | https://doi.org/10.1161/CIRCRESAHA.125.325515 Emerging Technologies and Future Directions in Interorgan Crosstalk Cardiometabolic Research

Hosung Bae^*, Christy M. Nguyen^*, Jorge Ruiz-Orera, Nicholas L. Mills, Michael P. Snyder, Cholsoon Jang, Svati H. Shah, Norbert Hübner, and Marcus Seldin

Department of Biological Chemistry and Center of Epigenetics and Metabolism, School of Medicine, University of California Irvine School of Medicine (H.B., C.M.N., C.J., M.S.). Cardiovascular and Metabolic Sciences, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany (J.R.-O., N.H.). BHF Centre for Cardiovascular Science (N.L.M.), The University of Edinburgh, United Kingdom. Usher Institute (N.L.M.), The University of Edinburgh, United Kingdom. Department of Genetics, Stanford University School of Medicine, CA (M.P.S.). Duke Center for Precision Health (S.H.S.), Duke University School of Medicine, Durham, NC. Duke Molecular Physiology Institute (S.H.S.), Duke University School of Medicine, Durham, NC. German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Germany (N.H.). Charité-Universitätsmedizin, Berlin, Germany (N.H.). Helmholtz Institute for Translational AngioCardioScience, MDC, Heidelberg University, Germany (N.H.).

^*H. Bae and C.M. Nguyen contributed equally.
Correspondence
Correspondence to: Marcus Seldin, PhD

Abstract

The heart does not work in isolation, with cardiac health and disease occurring through complex interactions between the heart with multiple organs. Furthermore, the integration of organ-specific lipid metabolism, blood pressure, insulin sensitivity, and inflammation involves a complex network of signaling pathways between many organs. Dysregulation in these communications is now recognized as a key contributor to many manifestations of cardiovascular disease. Mechanistic characterization of specific molecules mediating interorgan signaling has been pivotal in advancing our understanding of cardiovascular disease. The discovery of insulin, glucagon, and other hormones in the early 20th century illustrated the importance of communication between organs in maintaining physiological homeostasis. For example, elegant studies evaluating insulin signaling and its role in regulating glucose metabolism have shed light on its broader impact on cardiovascular health, hypertension, atherosclerosis, and other cardiovascular disease risks. Recent technological advances have revolutionized our understanding of interorgan signaling. Global approaches such as proteomics and metabolomics applications to blood have enabled the simultaneous profiling of thousands of circulating factors, revealing previously unknown signaling molecules and pathways. These large-scale studies have identified biomarkers linked to early stages of heart disease and offered new therapeutic targets. By understanding how specific cells in the heart interact with cells in other organs, such as the kidney or liver, researchers can identify key pathways that, when disrupted, lead to cardiovascular pathology. The ability to capture a more holistic view of the cardiovascular system positions interorgan signaling at the forefront of cardiovascular research. As we continue to refine our tools for mapping these complex networks, the insights gained hold the potential to not only improve early diagnosis but also to develop more targeted and effective treatments for cardiovascular disease. In this review, we discuss current approaches used to enhance our understanding of organ crosstalk with a specific emphasis on cardiac and cardiovascular physiology.

논문정보

형식Review Paper
게재일2025년 05월 (BRIC 등록일 2025-05-26)
연구진국외 연구진
분야 생명과학 > 생리학

댓글 작성 로그인

CV 열람하기

연락처 보기